AstraZeneca and BMS Jump on 340B Claims Data Submission Bandwagon For Entity-Owned Pharmacies

4/21/2026 – AstraZeneca and BMS Jump on 340B Claims Data Submission Bandwagon For Entity-Owned Pharmacies AstraZeneca and Bristol Myers Squibb (BMS) became the most recent manufacturers to require covered entities to submit data…

Drug Manufacturer AbbVie Sues HRSA Over the 340B Patient Definition

4/17/2026 – Drug Manufacturer AbbVie Sues HRSA Over the 340B Patient Definition Last week, the drug manufacturer AbbVie filed a federal lawsuit challenging HRSA’s long-standing definition of a 340B patient.…

Federal Court Strikes Down HRSA’s 2013 GPO Prohibition Policy

4/8/2026 – Federal Court Strikes Down HRSA’s 2013 GPO Prohibition Policy A federal court struck down the Health Resources and Services Administration’s (HRSA) 2013 policy requiring certain 340B hospitals to make their initial purchases…

Fourth Circuit Upholds Preliminary Injunction Blocking West Virginia’s Contract Pharmacy Protection Law

4/6/2026 – Fourth Circuit Upholds Preliminary Injunction Blocking West Virginia’s Contract Pharmacy Protection Law In a 2–1 decision, the  Fourth Circuit upheld a lower court’s preliminary injunction blocking West Virginia from…

Ninth Circuit Lays the Groundwork for Potential False Claims Act Liability of Manufacturers for 340B Overcharges

4/3/2026 – Ninth Circuit Lays the Groundwork for Potential False Claims Act Liability of Manufacturers for 340B Overcharges In a pivotal decision upholding False Claims Act (FCA) litigation against drug…